Elevation Oncology Inc. (ELEV)

ELEV trades at $0.38, 84.8% below the near-term max pain of $2.5 expiring Jul 18, 2025 (-36 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is stable across expirations ($2.5-$2.5), indicating stable market expectations. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ELEV shows stable levels around 2.50, reflecting balanced market expectations. The 0% spread suggests strong consensus on fair value. Most levels above 0.38 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.